90% Success: Exicure's Burixafor Helps Myeloma Stem Cell Collection

Exicure shares positive Phase 2 data on burixafor (GPC-100) showing reliable and rapid stem cell mobilization for autologous transplant in multiple myeloma patients, even those with prior challenging therapies.